Addgene: pCW57-GFP-2A-MCS Citations

pCW57-GFP-2A-MCS Citations (23)

Originally described in: Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer.
Barger CJ, Branick C, Chee L, Karpf AR Cancers (Basel). 2019 Feb 21;11(2). pii: cancers11020251. doi: 10.3390/cancers11020251. PubMed Journal

Articles Citing pCW57-GFP-2A-MCS

Showing 1 to 10 of 23 entries

Show entries

Search table:

Articles
Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML. Negri A, Ward C, Bucci A, D'Angelo G, Cauchy P, Radesco A, Ventura AB, Walton DS, Clarke M, Mandriani B, Pappagallo SA, Mondelli P, Liao K, Gargano G, Zaccaria GM, Viggiano L, Lasorsa FM, Ahmed A, Di Molfetta D, Fiermonte G, Cives M, Guarini A, Vegliante MC, Ciavarella S, Frampton J, Volpe G. Cell Death Dis. 2023 Nov 23;14(11):763. doi: 10.1038/s41419-023-06276-z. PubMed
Phosphorylation of TRF2 promotes its interaction with TIN2 and regulates DNA damage response at telomeres. Storchova R, Palek M, Palkova N, Veverka P, Brom T, Hofr C, Macurek L. Nucleic Acids Res. 2023 Feb 22;51(3):1154-1172. doi: 10.1093/nar/gkac1269. PubMed
Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome. Unda BK, Chalil L, Yoon S, Kilpatrick S, Irwin C, Xing S, Murtaza N, Cheng A, Brown C, Afonso A, McCready E, Ronen GM, Howe J, Caye-Eude A, Verloes A, Doble BW, Faivre L, Vitobello A, Scherer SW, Lu Y, Penzes P, Singh KK. Mol Psychiatry. 2023 Jan 6. doi: 10.1038/s41380-022-01937-5. PubMed
Multiparametric and accurate functional analysis of genetic sequence variants using CRISPR-Select. Niu Y, Ferreira Azevedo CA, Li X, Kamali E, Haagen Nielsen O, Storgaard Sorensen C, Frodin M. Nat Genet. 2022 Dec 5. doi: 10.1038/s41588-022-01224-7. PubMed Associated Plasmids pCW57-GFP-2A-Cas9
The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma. Gambi G, Mengus G, Davidson G, Demesmaeker E, Cuomo A, Bonaldi T, Katopodi V, Malouf GG, Leucci E, Davidson I. Cancer Res. 2022 Dec 16;82(24):4555-4570. doi: 10.1158/0008-5472.CAN-22-0959. PubMed
Gene-specific nonsense-mediated mRNA decay targeting for cystic fibrosis therapy. Kim YJ, Nomakuchi T, Papaleonidopoulou F, Yang L, Zhang Q, Krainer AR. Nat Commun. 2022 May 27;13(1):2978. doi: 10.1038/s41467-022-30668-y. PubMed
Human constitutive androstane receptor represses liver cancer development and hepatoma cell proliferation by inhibiting erythropoietin signaling. Li Z, Kwon SM, Li D, Li L, Peng X, Zhang J, Sueyoshi T, Raufman JP, Negishi M, Wang XW, Wang H. J Biol Chem. 2022 May;298(5):101885. doi: 10.1016/j.jbc.2022.101885. Epub 2022 Mar 30. PubMed
DDX50 Is a Viral Restriction Factor That Enhances IRF3 Activation. Pallett MA, Lu Y, Smith GL. Viruses. 2022 Feb 3;14(2). pii: v14020316. doi: 10.3390/v14020316. PubMed
Exon-skipping antisense oligonucleotides for cystic fibrosis therapy. Kim YJ, Sivetz N, Layne J, Voss DM, Yang L, Zhang Q, Krainer AR. Proc Natl Acad Sci U S A. 2022 Jan 18;119(3):e2114858118. doi: 10.1073/pnas.2114858118. PubMed
Regulation of Wnt/PCP signaling through p97/VCP-KBTBD7-mediated Vangl ubiquitination and endoplasmic reticulum-associated degradation. Feng D, Wang J, Yang W, Li J, Lin X, Zha F, Wang X, Ma L, Choi NT, Mii Y, Takada S, Huen MSY, Guo Y, Zhang L, Gao B. Sci Adv. 2021 May 14;7(20). pii: 7/20/eabg2099. doi: 10.1126/sciadv.abg2099. Print 2021 May. PubMed

If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.